The global dyslipidemia treatment market is experiencing significant growth in the coming years. This trend can be attributed to a increasing prevalence of cardiovascular diseases, coupled with an increase in the elderly population. The market is heavily influenced by key players who are regularly developing novel treatment options. Key segments w